Trials / Completed
CompletedNCT01703585
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
A Feasibility Study of Genomic Profiling Methods and Timing of Sample Collection to Evaluate Clonal Evolution and Tumor Heterogeneity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a feasibility study to look for genetic alterations in tissue and blood samples that may be useful in determining what treatments may be useful in the patient's cancer care.
Detailed description
As part of the study, patients will have archival tumor tissue collected, and have tumor biopsies and blood samples taken. The samples will be tested for genetic alterations, and the results will be discussed with the patient including potential treatments. If patients agree, after they have received treatment for their cancer and their disease progresses, a second biopsy procedure will be done.
Conditions
- Colorectal Cancer
- Breast Cancer
- Gynecological Cancer
- Metastatic
- Eligible for Phase I or Phase II Study
- Melanoma Cancer
Timeline
- Start date
- 2012-10-04
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2012-10-10
- Last updated
- 2018-05-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01703585. Inclusion in this directory is not an endorsement.